These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 29040348)

  • 1. deSUMOylation signaling: a novel mechanism of liver CSC properties and hepatocarcinogenesis in hypoxia.
    Zhao H; Yao P; Fu N; Chen L
    Acta Biochim Biophys Sin (Shanghai); 2017 Dec; 49(12):1135-1137. PubMed ID: 29040348
    [No Abstract]   [Full Text] [Related]  

  • 2. SENP1 promotes hypoxia-induced cancer stemness by HIF-1α deSUMOylation and SENP1/HIF-1α positive feedback loop.
    Cui CP; Wong CC; Kai AK; Ho DW; Lau EY; Tsui YM; Chan LK; Cheung TT; Chok KS; Chan ACY; Lo RC; Lee JM; Lee TK; Ng IOL
    Gut; 2017 Dec; 66(12):2149-2159. PubMed ID: 28258134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transarterial chemoembolization aggravated peritumoral fibrosis via hypoxia-inducible factor-1α dependent pathway in hepatocellular carcinoma.
    Qu K; Yan Z; Wu Y; Chen Y; Qu P; Xu X; Yuan P; Huang X; Xing J; Zhang H; Liu C; Zhang J
    J Gastroenterol Hepatol; 2015 May; 30(5):925-32. PubMed ID: 25641377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Artemin is hypoxia responsive and promotes oncogenicity and increased tumor initiating capacity in hepatocellular carcinoma.
    Zhang M; Zhang W; Wu Z; Liu S; Sun L; Zhong Y; Zhang X; Kong X; Qian P; Zhang H; Lobie PE; Zhu T
    Oncotarget; 2016 Jan; 7(3):3267-82. PubMed ID: 26675549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sorafenib in hepatocellular carcinoma.
    Josephs DH; Ross PJ
    Br J Hosp Med (Lond); 2010 Aug; 71(8):451-6. PubMed ID: 20852487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human carbonyl reductase 1 upregulated by hypoxia renders resistance to apoptosis in hepatocellular carcinoma cells.
    Tak E; Lee S; Lee J; Rashid MA; Kim YW; Park JH; Park WS; Shokat KM; Ha J; Kim SS
    J Hepatol; 2011 Feb; 54(2):328-39. PubMed ID: 21056497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Origin of hepatocellular carcinoma: role of stem cells.
    Wu XZ; Chen D
    J Gastroenterol Hepatol; 2006 Jul; 21(7):1093-8. PubMed ID: 16824058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dysadherin can enhance tumorigenesis by conferring properties of stem-like cells to hepatocellular carcinoma cells.
    Park JR; Kim RJ; Lee YK; Kim SR; Roh KJ; Oh SH; Kong G; Kang KS; Nam JS
    J Hepatol; 2011 Jan; 54(1):122-31. PubMed ID: 20952084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypoxia inducible factor in hepatocellular carcinoma: A therapeutic target.
    Lin D; Wu J
    World J Gastroenterol; 2015 Nov; 21(42):12171-8. PubMed ID: 26576101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypoxia and hepatocellular carcinoma: The therapeutic target for hepatocellular carcinoma.
    Wu XZ; Xie GR; Chen D
    J Gastroenterol Hepatol; 2007 Aug; 22(8):1178-82. PubMed ID: 17559361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipopolysaccharide supports maintaining the stemness of CD133(+) hepatoma cells through activation of the NF-κB/HIF-1α pathway.
    Lai FB; Liu WT; Jing YY; Yu GF; Han ZP; Yang X; Zeng JX; Zhang HJ; Shi RY; Li XY; Pan XR; Li R; Zhao QD; Wu MC; Zhang P; Liu JF; Wei LX
    Cancer Lett; 2016 Aug; 378(2):131-41. PubMed ID: 27208741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An association of sarcoidosis with hepatocellular carcinoma.
    Chalasani P; Vohra M; Sheagren JN
    Ann Oncol; 2005 Oct; 16(10):1714-5. PubMed ID: 15972280
    [No Abstract]   [Full Text] [Related]  

  • 13. Time-dependent effect of hypoxia on tumor progression and liver progenitor cell markers in primary liver tumors.
    Bogaerts E; Heindryckx F; Devisscher L; Paridaens A; Vandewynckel YP; Van den Bussche A; Verhelst X; Libbrecht L; van Grunsven LA; Geerts A; Van Vlierberghe H
    PLoS One; 2015; 10(3):e0119555. PubMed ID: 25793288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor microenviroment and hepatocellular carcinoma metastasis.
    Wang H; Chen L
    J Gastroenterol Hepatol; 2013 Aug; 28 Suppl 1():43-8. PubMed ID: 23855295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histone deacetylase 5 promotes the migration and invasion of hepatocellular carcinoma via increasing the transcription of hypoxia-inducible factor-1α under hypoxia condition.
    Ye M; Fang Z; Gu H; Song R; Ye J; Li H; Wu Z; Zhou S; Li P; Cai X; Ding X; Yu S
    Tumour Biol; 2017 Jun; 39(6):1010428317705034. PubMed ID: 28653891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatocarcinogenesis: a dynamic cellular perspective.
    Farber E; Sarma DS
    Lab Invest; 1987 Jan; 56(1):4-22. PubMed ID: 3025514
    [No Abstract]   [Full Text] [Related]  

  • 17. Heterogeneity of hepatocellular carcinoma contributes to cancer progression.
    Jeng KS; Chang CF; Jeng WJ; Sheen IS; Jeng CJ
    Crit Rev Oncol Hematol; 2015 Jun; 94(3):337-47. PubMed ID: 25680939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Percutaneous echo-guided alcoholization in hepatocellular carcinoma complicating cirrhosis. Plea for the use of elevated volumes of alcohol].
    Bastid C; Schönenberg P; Zouiten K; Guedes J; Sahel J
    Gastroenterol Clin Biol; 1992; 16(2):187-9. PubMed ID: 1314746
    [No Abstract]   [Full Text] [Related]  

  • 19. Cancer stem cells in hepatocellular carcinomas.
    Das P; Gupta SD
    Indian J Med Res; 2015 Oct; 142(4):362-5. PubMed ID: 26609026
    [No Abstract]   [Full Text] [Related]  

  • 20. Existence of cancer stem cells in hepatocellular carcinoma: myth or reality?
    Machida K
    Hepatol Int; 2017 Mar; 11(2):143-147. PubMed ID: 27990610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.